2077
4D flow MRI for assessment of blood flow in hepatic arteries of patients with HCC treated with transarterial chemoembolization: a pilot study
Rihab Mansour1, Narges Salehi2, William Tanguay1,3, Guillaume Gilbert4, Catherine Huet1, Gilles Soulez1, Pierre Perreault1, Damien Olivé 1, An Tang1,3, and Samuel Kadoury1,2
1Centre de recherche du Centre hospitalier de l'Université de Montréal (CRCHUM), Montréal, QC, Canada, 2École Polytechnique, Montréal, QC, Canada, 3Department of Radiology, Radio-Oncology and Nuclear Medicine, Université de Montréal, Montréal, QC, Canada, 4MR Clinical Science, Philips Healthcare Canada, Markham, ON, Canada
4D flow MRI measurements in the abdominal aorta, common hepatic artery, and proper hepatic arteries are feasible and provide repeatable values before and after transarterial chemoembolization in patients with hepatocellular carcinoma.
Figure 1. 3D segmentation at the level of the abdominal aorta (upper left) and corresponding 4D flow particle tracing from a 68-year-old man (lower left). Representative flow curves in the abdominal aorta, common hepatic artery and proper hepatic artery (right).
Table 2. Statistical analysis between pre- and post-TACE for abdominal aorta, common hepatic artery, and proper hepatic artery.